NCT06330220View on ClinicalTrials.gov

Visual Function Change in Wet Age-related Macular Degeneration Patients With Better Baseline Visual Acuity

PHASE4CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

February 10, 2021

Primary Completion Date

February 28, 2022

Study Completion Date

February 28, 2022

Conditions
Age-Related Macular Degeneration
Interventions
DRUG

Aflibercept Injection [Eylea]

intravitreal injection

Trial Locations (1)

03080

Seoul National University Hospital, Seoul

All Listed Sponsors
lead

Seoul National University Hospital

OTHER

NCT06330220 - Visual Function Change in Wet Age-related Macular Degeneration Patients With Better Baseline Visual Acuity | Biotech Hunter | Biotech Hunter